Try our Advanced Search for more refined results
Life Sciences - September, 2012
237 articles
- Fed. Circ. Backs Ban On Generic Treximet
- FDA Approves Wider Humira Use Despite Efficacy Concerns
- Jury Hears From Teen Boy's Doc At Risperdal Trial
- Novartis Escapes Long-Running Farmers' Pesticide Suit
- Brand-Name, Generic Reglan Makers Beat Injury Suit
- FDA Loss May Draw Drug-Device Makers To Policy Fight
- Dentsply Can't Ax Suit Alleging Dental Tool Defects
- Sham Litigation Claims Nixed In Androgel Pay-For-Delay MDL
- Abbott Diabetes Monitor Patent Revived By Fed. Circ.
- Healthpoint Settles $90M Medicaid Fraud Suit Over Xenaderm
- Vivus Escapes Shareholder Suit Over Obesity Drug Safety
- JPML Ships 5 Fen-Phen Suits Against Wyeth, Pfizer To Pa. MDL
- Medtronic Goes Wide In China With $816M Device Maker Buy
- Stryker Says Wright Medical Copied Implant Name For Website
- Food Labeling Suits: An Explosive Trend In Tort System
- GAO Calls For Greater FDA Scrutiny On Device Hacking Risk
- Boehringer Can Keep Many Docs On Barr Deal Away From FTC
- Lilly Nets Another 2nd Circ. Win In Zyprexa MDL
- Medicare Wrongly Paid $25M For Painkiller Refills, HHS Says
- Novartis Wants Pesticide Suit Nixed For Discovery Failing
- Obama, Romney Duel Over Health Care Ahead Of 1st Debate
- Reckitt Asks FDA To Require Opioid Drug Childproofing
- Top 5 Corruption Risks For Pharmaceutical Cos.
- Bayer, Class Reach Deal In One-A-Day Prostate False Ad Suit
- Judge To Keep J&J CEO Off Stand In Risperdal Case
- Pain Therapeutics Gets Investors' Painkiller Suit Nixed
- Breast Implant Scandal Spurs EU To Strengthen Device Regs
- Smith & Nephew Issues Warning On Metal Hip Device
- J&J Can't Use Mensing To Keep Metal Hip Case Federal
- New Plan To Double Drug Approvals Offers Few Fresh Ideas
- HHS Passes Clinical Trial Reporting Authority To FDA
- Merck Investors Win Class Cert. In 2 Suits Over Vytorin
- Philly Court Boots Accutane Cases From Mass Tort System
- Astellas Skirts $867M Antitrust Suit Over Heart Test Drug
- Biopharma Co. Sues Over Cancer Drug Clinical Trial Mix-Up
- FDA Wrongly Denied Orphan Drug Exclusivity, Depomed Claims
- Shareholder Sues Life Science Co. Over $118M Merger
- AstraZeneca To Pay $11M To Settle Toprol-XL Antitrust Claims
- Jury Finds For J&J Unit In Row Over Abbott Antibody Patents
- McDermott Gets Go-Ahead To Work Tekmira Patent Case
- Breg Can't Escape Pain Pump Injury Suit
- Bayer, Others Ask High Court To Review Pay-For-Delay Case
- Janssen Promoted Risperdal Off Label, Jury Hears
- FDA Issues Guidance On Proving Generic-Drug Stability
- Stryker Recalls Neptune Devices After Death Reported
- Roche Bid Raises Prospect Of Mass Tort Exodus From Philly
- DOJ Unlikely To Spend Scarce Time, Money On Olympus Case
- Justices Expected To Write Final Chapter On Gene Patents
- 9th Circ. Affirms Merck's Win In Vaccine Wrongful Death Suit
- Patient Suing Stryker Can't Get Calif. Hospital Records
- Arnold & Porter Accused Of 'Egregious' Conflict In Patent Case
- Case Study: In Re Rigel Pharma Securities Litigation
- Ethypharm Urges 3rd Circ. To Revive Abbott Antitrust Row
- Fundamental Research Can Still Implicate Export Controls
- King & Spalding Lands IP Deals Pro From Davis Polk
- Metal Implant Patients Should Get Blood Tests, Australia Says
- Warner Chilcott Hit With Suit Over Doryx Market Misdeeds
- Risperdal Caused Teen Boy's Breast Growth, Jury Hears
- LabCorp Says VA Slammed Door On Its $32M Contract Bid
- Covidien Unit To Buy Specialty Drug Co. For $100M
- USTR Takes Israel Off IP Priority Watch List
- New FDA Team Seeks To Spur Antibiotics Innovation
- Judge Pares Suit Over Pfizer's Yanked Feed Additive
- Health Care Pro Joins Edwards Wildman From DOJ
- Merck To Pay Up To $10M To Settle Coppertone False Ad Suit
- Bankrupt K-V Fights Hologic Bid To Reacquire Makena Rights
- Fed. Circ. Knocks Inventors' DNA Patent As Too Obvious
- Congress OKs Last-Minute Fix To Save $250M In FDA Fees
- Ill. Can't Make Pharmacists Dispense Plan B, Court Says
- Freshfields Guides Advent In Proposed $1B Mediq Buy
- Avoiding OSHA Citations In Food And Beverage Industry
- EU Committee Backs Pfizer-BMS Anti-Clotting Drug
- IRS Can't Dodge Bayer's $65M Tax Credit Suit
- SEC Sues Syringe Maker For Allegedly Inflating Stock
- Drug Biz Worried Over User Fees' Fate Under Sequestration
- Church & Dwight Should Ax 'First, Only' Ovulation Claim: NAD
- Cytori Protests FDA's Cold Shoulder Toward Its Devices
- Mixing Agency Rules May Mean More Taxable Medical Devices
- Stryker Pays $1.5M To End Investors' Kickback, FCA Suits
- Three Bayer Probiotics False Ad Class Actions Revived
- Orthofix, Pfizer FCPA Cases A Sign Of What's To Come
- Gerber Urges MDL Panel To Consolidate Baby Formula Suits
- SLU's $7M Medtronic Royalties Suit Removed To Colo.
- NuVasive Says J&J Units Poached Medical Device Sales Rep
- J&J CEO Won't Take Stand In Risperdal Breast-Growth Trial
- Obama Admin's Welfare Waiver Rule Snubbed By House
- Biomet Raises Specter Of New Suits To Fight Hip-Implant MDL
- FTC Sets Sights On High Court Pay-For-Delay Fight
- Roche Picks NY Over NJ For New Research Center Location
- Santaris Can't Skirt Isis Suit Over Drug Development Deals
- Spotlight On BPA: Science And Litigation
- Watson Sued By Fertility Drug Rival Over Ad Campaign
- Osteoarthritis Pills Tainted With Lead, Class Action Says
- Politics Delay Senate Vote On 6-Month Stopgap Budget
- Baxter Execs Beat Investor Suit Over $588M Pump Recall
- House Clears Bipartisan Bill To Ramp Up Pediatric Research
- Novartis Prevails In Cancer Patient's Zometa Injury Suit
- FDA Tells High Court Warning Letters Aren't Final Actions
- Allergan Secretly Records Customer Calls, Suit Says
- Chantix Plaintiffs Can Gun For Punitive Damages In Bellwether
- Public Health Pro Rejoins Ropes & Gray From Harvard
- McKesson Pegged With Price Inflation Claims On 400-Plus Drugs
- Judge Keeps Sales Ban In Cephalon Generic Amrix Patent Row
- Doctor Convicted On False Fen-Phen Injury Claims
- Gibson Dunn Nabs Life Sciences IP Partner For Dallas Office
- Latham Guides Boston Scientific's Heart Catheter Maker Buy
- Pfizer Loses Bid To Invalidate Bayer's Bovine Drug Patent
- Mirapex May Increase Heart Failure Risk, FDA Says
- Bard Beats Contract Claim In Catheter Trade Secrets Fight
- Prescriptions For Life Science Investing
- New Concepts Under FTC Rule For Pharma Patent Deals
- Lessons From In Re Rigel Pharmaceuticals
- Pfizer's Neurontin Marketing Hurt Payors, 1st Circ. Hears
- Pharmacies Ill-Prepared For Potential DEA Crackdown
- Ariosa Asks USPTO To Nix Sequenom Prenatal Test Patent
- Attys Want J&J CEO To Testify In Risperdal Breast-Growth Case
- FDA Issues Warning For Over-The-Counter Diarrhea Drug
- Fed. Circ. Clarifies Burden Of Proof In Medtronic IP Case
- Wyeth Investors Win Class Cert. In Suit Over Pristiq Risks
- FDIC, Insurers Reach Deal In $25M Westernbank Claim Fight
- Plavix False Marketing Suit Kicked To State Court
- Merck Bashes Lawsuits Over Prescription Copay Coupons
- RICO Suit Over Sanofi Antibiotic Should Be Tossed, Judge Says
- Merck Strikes Damages Deal In Fosamax Bellwether Case
- Apotex Defeats Allergan's New Suit Over Pinkeye Patent
- Alaven Seeks $10M From Insurers For Reglan Defense
- Past Metal-Hip Fights May Haunt Biomet's Bid To Avoid MDL
- Avandia Heart Attack Plaintiffs Want Suits Out Of MDL
- Harvard Sues USPTO For Invalidating Mice-Testing Patent
- Democrat Moves To Allow Medicare Drug Price Negotiations
- O'Melveny Reps Chinese Co. In $118M Complete Genomics Deal
- GE, Cardinal Escape Antitrust Class Action Over Imaging Drug
- Pfizer Tells High Court Bankruptcy Law Protects Parent Cos.
- Judge Tosses FCA Suit Over Purdue's OxyContin
- Male Supplement Fails To Live Up To Hype, Suit Says
- Actelion Sues To Keep Tracleer Away From Apotex, Roxane
- Calif. Court Upholds Ex-Sequenom Exec's Defamation Claim
- FDA Budget To Plunge By $319M If Sequester Takes Effect
- K-V Gets Judge's OK To Use Cash Collateral To Boost Biz
- Impax Settles IP Row With J&J Over Generic Concerta
- RSUI Off Hook For $65M Forest Lab Drug Info Settlement
- Widow Urges High Court To Hear Novartis Bone Drug Dispute
- FDA Gives Medical Device Makers More Time To Mull ID Rule
- Avanir Sues Rivals Over Plans For Generic Neurological Drug
- Taking Stock: The AIA At 1 Year
- A Primer On Alternative Fee Arrangements
- Bayer Snaps Up Teva Animal Health Unit In $145M Deal
- House Passes Stopgap Bill To Fund Government For 6 Months
- Greenberg Traurig Still On Hook For Burned Doc, Atty Says
- McKesson Investor Targets Execs Over Drug Price-Rigging
- Fla. Man Gets 10 Years For $55M Drug Diversion Scheme
- Neogenix — A Cautionary Tale
- House Panel Moves To Block HHS Welfare Waiver Rule
- Bengay, Other Pain Relievers Can Cause Burns, FDA Says
- Morgan Lewis Helps Perrigo Fetch Pet Care Co. For $285M
- Regeneca Latest To Receive DMAA Warning From FDA
- $52M Jury Verdict Overturned In Gene Test Patent Row
- Down On The Farm Bill: A Drought-Like Outlook
- Eye Med Distributor Lobs $100M Suit Over Supply Contract
- OTC Drug Ads Rarely Mention Risks, Study Finds
- Novel Latest Drugmaker Sued By Purdue Over Insomnia Drug
- TPG's $2B Par Pharma Buyout Bid Harms Investors, Suit Says
- Blackstone Can't Claim $4M For Sun Pharma Deal, Taro Says
- Medicis Investor Sues To Halt $2.6B Valeant Buyout
- Merck & Cie Tells ITC Rivals Infringed Supplement Patents
- 3SBio Priced At $331M In Go-Private Buyout Offer
- Braintree Takes Cypress To Court Over Generic Suprep
- FCC Spectrum Commitment Opens Door To Mobile Medical Care
- Otsuka Targets Apotex In Latest Suit Over Generic Abilify
- Addressing The Scope Of CAFA In Supreme Court
- DEA Strips 2 CVS Pharmacies Of Drug Licenses
- Stryker Hit With 7 More Suits Over Metal Hip Implants
- House Mulls Quick-Fix Spending Bill To Buy 6 More Months
- Life Sciences Rise In Value Despite Venture Capital Dropoff
- J&J Wins Patent Dispute Over Birth Control Drug
- EU Lawmakers Vote To Strengthen Drug Safety Regime
- FDA Test-Drives New Risk-Benefit Framework
- Wyeth Asks Pa. High Court To Drop $8.6M Prempro Punitives
- FCPA Liability In M&A: Lessons From Pfizer Settlements
- Medicare Medical Equipment Bidding Flawed, Panel Hears
- Mayer Brown Scores Kilpatrick Patent Litigation Pro
- Ex-Pharmacy Directors Hit UHS, Drugmakers With FCA Suit
- Industry Points Out Transparency Issues With FDA Device Plan
- 9th Circ. Vacates $60M NuVasive Trademark Verdict
- J&J Settles Pa. Risperdal Lawsuit On Opening Day Of Trial
- Doctor Accuses J&J, Others Of Treading On Surgical Patents
- Xanodyne Gets Most State Claims Booted From Darvocet MDL
- MannKind To Pay $23M In Investor Suit Over Diabetes Drug
- GSK Not Liable For Homicide Linked To Paxil Generic: Judge
- Kimberly-Clark, Cardinal Renew Surgery Scrubs False Ad Fight
- Stryker Will Pay $4.25M To End Sales Rep Expense Claims
- Pfizer Hit With $5M Jury Verdict In Prempro Battle
- Medical Device Maker Seeks To Escape Soured Sales Deal
- Salix, Dr. Falk Sue Lupin Over Generic Version Of Apriso
- 2nd Circ. Lets Lilly Off Hook In Zyprexa Diabetes Suit
- Health Issues Top Agenda As Congress Returns
- FDA Eyes More Savvy Post-Approval Device Monitoring
- CORRECTED: Jefferson Gets Dibs On Patents From Cancer Doc's Research
- Pain Patch Maker Demands Coverage Of False Ad Suit
- Spotlight On Calif.'s Food Labeling Lunge
- Novartis Ruling Helps NJ Drug Cos. Fend Off Punitive Damages
- K-V Can't Challenge FDA Enforcement Decisions, Judge Rules
- PSLRA Claims Need Proof Of False Statements: 9th Circ.
- FDA Beats EU On Cancer Drugs, But Not Others, Study Shows
- Genentech, Xoma Beat Raptiva Warning Suit In 6th Circ.
- GAO Welfare Ruling Adds Congress To Agency Rulemaking Mix
- HHS Must Focus On Health IT For Crucial Reforms, IOM Says
- Shire Settles Patent Battle With Par Unit Over ADHD Drug
- Judge Nixes $7.8M Orthofix Medicare Fraud Plea
- Morgan Lewis Lures Food And Drug Team From K&L Gates
- Hologic Asks To Pursue Makena Claims Against K-V Pharma
- Fresenius Can't Stay Fed. Circ. Appeal Of $24M IP Judgment
- Smith & Nephew Wins $4M In Surgical Device Patent Suit
- Age Of The Whistleblower: Incentives And Protections
- FDA Fast-Track Program May Harm Patient Safety, Study Says
- Genzyme, Impax Bury Hatchet Over Kidney Disease Drugs
- Sunshine Act Authors Urge CMS To Finalize Rule
- Choate Takes On Life Sciences Co-Chair From Infinity Pharma
- Skadden Adds Ex-WilmerHale Global Corporate Head In Boston
- Celera Can't Duck Shareholder Suit Over Financial Reports
- FDA Sued Over Delay On Pfizer Alzheimer's Drug Decision
- FDA Fights Back Against ViroPharma's Generic Vancocin Suit
- Bayer Beats FCA Suit Over Off-Label Yaz Marketing
- Cozen O'Connor Bolsters IP, Insurance Groups With 2 Hires
- Fed. Circ. Revives Santarus' Suit Over Par's Generic Zegerid
- Ropes & Gray Boosts DC Life Sciences Group With PE Pro
- Merck Resolves $220M Vioxx Loss Claims In 5th Circ.
- Democrats Say ACA Not End of Health Reform
- Seyfarth Shaw Lands Apotex's Ex-IP Head For Chicago Office
- Merge, Commed Hit With FDA Warnings Over Facility Violations
- Ex-Bayer Exec Says Criticism Of Aleve Claims Led To Firing
- GSK Whistleblowers Slam 'Excessive' $30M Fee Request
- Parents Say Wyeth's Effexor Caused Birth Defects
- GSK ERISA Class Action Overblown, 2nd Circ. Says
- Celgene, Agios Settle $1B UPenn Cancer Research Suits
- Sullivan, Skadden Rep Valeant In $2.6B Skin Care Co. Buy
- The Practical Lessons Of Myriad